Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-11-23
1990-01-02
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514195, 540310, C07D49900, A61K 31425
Patent
active
048913693
ABSTRACT:
Disclosed are 2.beta.-substituted-methylpenicillanic acid compounds of the formula ##STR1## wherein n is 0, 1 or 2; and ##STR2## is monocyclic or bicyclic heterocyclic ring group which has 2 to 4 nitrogen atoms as hetero atom in its ring structure and which may be optionally substituted with alkyl, alkoxycarbonyl, phenyl, formyl or benzyloxycarbonyl optionally having alkyl, nitro or a halogen atom on the benzene ring, with the proviso that said heterocyclic ring group is not 1,2,3-triazol-1-yl; or salts or esters thereof.
These compounds are useful as .beta.-lactamase inhibitor.
REFERENCES:
patent: 4529592 (1985-07-01), Micetich et al.
patent: 4562073 (1985-12-01), Micetich et al.
patent: 4668514 (1987-05-01), Mictich et al.
Nakai Akira
Ohbayashi Hisashi
Ohno Tomoyasu
Tanaka Hideo
Tanaka Motoaki
Rizzo Nicholas S.
Taiho Pharmaceutical Company Limited
LandOfFree
2.beta.-Substituted-methylpenicillanic acid derivatives, and sal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2.beta.-Substituted-methylpenicillanic acid derivatives, and sal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2.beta.-Substituted-methylpenicillanic acid derivatives, and sal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383843